Intravenous (IV) iron is the therapy of choice when oral iron is ineffective or poorly tolerated,
yet use has been limited by fears of hypersensitivity reactions (HSRs). Newer formulations …

Iron deficiency anemia (IDA) is common in many chronic diseases, and intravenous (IV) iron
offers a rapid and efficient iron correction. This trial compared the efficacy and safety of iron …

For the majority of patients with iron deficiency anemia (IDA), a full course of intravenous (IV)
iron is 1 g. Most IV irons require 5–10 administrations of 100–300 mg. We have successfully …

There are multiple intravenous (IV) iron formulations available, of which several may be
administered as single‐dose infusions such as low‐molecular weight iron dextran (LMWID) …

Iron deficiency anemia (IDA) is prevalent, and intravenous iron, especially if given in a single
dose, may result in better adherence compared with oral iron. The present trial (FERWON …

Although oral iron is the initial treatment approach for iron deficiency anemia (IDA), some
patients fail to respond to or cannot tolerate oral iron. This double‐blind safety and efficacy …

ABSTRACT Introduction: Originally approved in Europe in 2009, ferric derisomaltose is the
most recently authorized intravenous iron compound in the United States of America (2020) …

Iron deficiency anemia (IDA) is the most common form of anemia worldwide. Although oral
iron is used as first‐line treatment, many patients are unresponsive to or cannot take oral …

Currently available IV iron agents pose substantial safety and practical challenges to
effective management of iron deficiency anemia. Iron dextran administration requires a test …

Oral iron is a standard treatment of iron deficient anemia despite high rates of intolerance
and nonadherence and may not replenish iron stores rapidly enough to meet ongoing …